Journal
PARASITOLOGY RESEARCH
Volume 116, Issue 2, Pages 495-502Publisher
SPRINGER
DOI: 10.1007/s00436-016-5310-0
Keywords
Antiviral activity; Malaria; Magnetospirillum gryphiswaldense; Magnetotactic bacteria; Yellow fever; Zika virus
Categories
Funding
- Deanship of Scientific Research, King Saud University, Saudi Arabia [RGP-1435-057]
- PROAPI (PRAF)
- University of Pisa, Department of Agriculture, Food and Environment [COFIN2015_22]
- Grants-in-Aid for Scientific Research [15K06591] Funding Source: KAKEN
Ask authors/readers for more resources
A main challenge in parasitology is the development of reliable tools to prevent or treat mosquito-borne diseases. We investigated the toxicity of magnetic nanoparticles (MNP) produced by Magnetospirillum gryphiswaldense (strain MSR-1) on chloroquine-resistant (CQ-r) and sensitive (CQ-s) Plasmodium falciparum, dengue virus (DEN-2), and two of their main vectors, Anopheles stephensi and Aedes aegypti, respectively. MNP were studied by Fourier-transform infrared spectroscopy and transmission electron microscopy. They were toxic to larvae and pupae of An. stephensi, LC50 ranged from 2.563 ppm (1st instar larva) to 6.430 ppm (pupa), and Ae. aegypti, LC50 ranged from 3.231 ppm (1st instar larva) to 7.545 ppm (pupa). MNP IC50 on P. falciparum were 83.32 mu g ml(-1) (CQ-s) and 87.47 mu g ml(-1) (CQ-r). However, the in vivo efficacy of MNP on Plasmodium berghei was low if compared to CQ-based treatments. Moderate cytotoxicity was detected on Vero cells post-treatment with MNP doses lower than 4 mu g ml(-1). MNP evaluated at 2-8 mu g ml(-1) inhibited DEN-2 replication inhibiting the expression of the envelope (E) protein. In conclusion, our findings represent the first report about the use of MNP in medical and veterinary entomology, proposing them as suitable materials to develop reliable tools to combat mosquito-borne diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available